(Press-News.org) When millions of people are bracing themselves for the onslaught of extreme weather, as much information as possible is needed to predict the strength of the impending storm. ESA's SMOS mission again showed its versatility by capturing unique measurements of Hurricane Sandy.
As its name suggests, the Soil Moisture and Ocean Salinity (SMOS) satellite was designed to measure how much moisture is held in soil and how much salt is held in the surface waters of the oceans.
This information is helping to improve our understanding of the water cycle – an essential component of the Earth system.
However, this state-of-the-art Earth Explorer mission has demonstrated that its instrumentation and measuring techniques can be used to offer much more.
Since SMOS has the ability to see through clouds and it is little affected by rain, it can also provide reliable estimates of the surface wind speeds under intense storms.
Parts of the Caribbean and northeastern US are still suffering the aftermath of Hurricane Sandy, which is the largest Atlantic hurricane on record.
Unusually, Sandy was a hybrid storm, tapping energy from the evaporation of seawater like a hurricane and from different air temperatures like a winter storm. These conditions generated a super storm that spanned an incredible 1800 km.
As it orbited above, the satellite intercepted parts of Hurricane Sandy at least eight times as the storm swept over Jamaica and Cuba around 25 October, until its landfall in New Jersey, US, four days later.
The data from these encounters have been used to estimate the speed of the wind over the ocean's surface.
SMOS carries a novel microwave sensor to capture images of 'brightness temperature'. These images correspond to radiation emitted from the surface of Earth, which are then used to derive information on soil moisture and ocean salinity.
Strong winds over oceans whip up waves and whitecaps, which in turn affect the microwave radiation being emitted from the surface. This means that although strong storms make it difficult to measure salinity, the changes in emitted radiation can, however, be linked directly to the strength of the wind over the sea.
This method of measuring surface wind speeds was developed by scientists at the French Research Institute for Exploration of the Sea and Collect Localisation Satellites, CLS, within ESA's Earth Observation Support to Science Element programme.
The method was originally used during Hurricane Igor in 2010, but has again proven accurate. During Hurricane Sandy, SMOS data compare well with realtime measurements from meteorological buoys as the super storm passed between the coast of the US and the Bermuda Islands.
Moreover, NOAA's Hurricane Research Division flew a P-3 aircraft seven times into Hurricane Sandy to gather measurements of surface wind speeds, rain and other meteorological parameters. One of these airborne campaigns coincided with an overpass of the satellite.
Keeping in mind the significantly differing sampling characteristics between the SMOS radiometer and the aircraft sensor, there was excellent agreement in the measurements. Both instruments consistently detected a wind band 150 km south of the hurricane eye, with a speed of just over 100 km/h.
Being able to measure ocean surface wind in stormy conditions with the synoptic and frequent coverage of SMOS is paramount for tracking and forecasting hurricane strength.
Although ESA's Earth Explorers are developed to address specific scientific issues, they continue to demonstrate their versatility.
INFORMATION:
Super storm tracked by European Space Agency water mission
2012-11-09
ELSE PRESS RELEASES FROM THIS DATE:
A scientific explanation to why people perform better after receiving a compliment
2012-11-09
A team of Japanese scientists have found scientific proof that people doing exercises appear to perform better when another person compliments them. The research was carried out by a group lead by National Institute for Physiological Sciences Professor Norihiro Sadato, Graduate University for Advanced Studies graduate student Sho Sugawara, Nagoya Institute of Technology Tenure-Track Associate Professor Satoshi Tanaka, and in collaboration with Research Center for Advanced Science and Technology Associate Professor Katsumi Watanabe. The team had previously discovered that ...
Understanding antibiotic resistance using crystallography and computation
2012-11-09
Increasingly, bacteria such as E. coli are resisting the action of carbapenems by producing enzymes (carbapenemases) that break a specific chemical bond in the antibiotic, destroying its antimicrobial activity.
Carbapenemases are members of the group of enzymes called beta-lactamases that break down penicillins and related antibiotics, but it has not been clear why carbapenemases can destroy carbapenems while other beta-lactamases cannot.
Using molecular dynamics simulations, Professor Adrian Mulholland in the School of Chemistry and Dr Jim Spencer in the School of ...
ADHD medicine affects the brain's reward system
2012-11-09
A group of scientists from the University of Copenhagen has created a model that shows how some types of ADHD medicine influence the brain's reward system. The model makes it possible to understand the effect of the medicine and perhaps in the longer term to improve the development of medicine and dose determination. The new research results have been published in the Journal of Neurophysiology.
In Denmark approximately 2-3 per cent of school-age children satisfy diagnostic criteria for ADHD, and therefore it is crucial to know how the medicine works. With a new mathematical ...
New mechanism of action for PARP inhibitors discovered
2012-11-09
PHILADELPHIA — New understanding of how drugs called PARP inhibitors, which have already shown promise for the treatment of women with familial breast and ovarian cancers linked to BRCA mutations, exert their anticancer effects has led to the identification of ways in which the patient population that might benefit from PARP inhibitors could be expanded.
Yves Pommier, M.D., Ph.D., chief of the Laboratory of Molecular Pharmacology at the National Cancer Institute's Center for Cancer Research in Bethesda, Md., and colleagues reported these data in Cancer Research, a journal ...
Link found between child prodigies and autism
2012-11-09
COLUMBUS, Ohio - A new study of eight child prodigies suggests a possible link between these children's special skills and autism.
Of the eight prodigies studied, three had a diagnosis of autism spectrum disorders. As a group, the prodigies also tended to have slightly elevated scores on a test of autistic traits, when compared to a control group.
In addition, half of the prodigies had a family member or a first- or second-degree relative with an autism diagnosis.
The fact that half of the families and three of the prodigies themselves were affected by autism is surprising ...
Study questions the relevance of SCIP benchmarks among CABG patients
2012-11-09
(Boston) – Cardiothoracic surgeons and endocrinologists from Boston Medical Center (BMC) have found that among patients undergoing coronary artery bypass graft (CABG) surgery, achieving Surgical Care Improvement Project (SCIP) benchmarks for glycemic control may be irrelevant when perioperative continuous insulin infusion protocols are implemented. These findings appear on-line in the Journal of Thoracic and Cardiovascular Surgery.
Currently, 40 percent of all patients undergoing CABG suffer from diabetes, and this number is quickly rising. Traditionally these patients ...
Belatacept after a kidney transplant: Minor added benefit for certain patients
2012-11-09
Belatacept (trade name Nulojix®) has been approved since June 2011 to prevent a rejection reaction of the body to the donor organ (transplant) in adults who have received a kidney transplant. The Institute for Quality and Efficiency in Health Care (IQWiG) has examined the added benefit of the drug pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG).
The assessment showed an indication of a minor added benefit of belatacept in adults with transplants from donors who had been selected according to the so-called standard criteria. Serious side ...
Moffitt Cancer Center researchers identify novel metabolic programs driving aggressive brain tumors
2012-11-09
Researchers at Moffitt Cancer Center have identified metabolic signatures that may pave the way for personalized therapy in glioma, a type of tumor that starts in the brain.
The study appears online in the October issue of Cancer Research, a publication of the American Association for Cancer Research.
According to the authors, little has been known about the underlying metabolic alterations that may drive the growth of the most aggressive type of glioma, termed glioblastoma.
"For the first time, we have described global metabolomic signatures in glioma," said study ...
Considerable added benefit of ipilimumab in advanced melanoma
2012-11-09
The humanized antibody ipilimumab (trade name Yervoy®) has been approved since August 2011 for the treatment of adult patients with advanced melanoma (black skin cancer) who have already been treated. The term "advanced" means that the melanoma can no longer be removed by an operation or that metastases have formed. The German Institute for Quality and Efficiency in Health Care (IQWiG) has examined the added benefit of the drug pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG). According to the findings, the drug offers major advantages with ...
University of Huddersfield physicist investigates the Big Bang particle
2012-11-09
Scientists at the University of Huddersfield are collaborating with experts at some of the world's leading research institutes in an attempt to unravel the mysteries of a particle that played a role in the creation of the universe.
The existence of neutrinos and anti-neutrinos – particles that are almost massless and which travel at light speed from one side of the earth to the other – was confirmed more than 50 years ago. Scientists believe that they were created at the Big Bang and might hold the key to the nature of the universe.
But they are light particles that ...